brilaroxazine (RP5063) / Reviva  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
brilaroxazine (RP5063) / Reviva
NCT01490086: RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Checkmark REFRESH trial in schizophrenia
Oct 2016 - Oct 2016: REFRESH trial in schizophrenia
Completed
2
234
US, RoW
RP5063, placebo, aripiprazole
Reviva Pharmaceuticals
Acute Schizophrenia, Schizoaffective Disorder
03/13
03/13

Download Options